Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1973 Aug 4;3(5874):257–260. doi: 10.1136/bmj.3.5874.257

Acute Intermittent Porphyria: Response of Tachycardia and Hypertension to Propranolol

A D Beattie, M R Moore, A Goldberg, R L Ward
PMCID: PMC1586759  PMID: 4723462

Abstract

In four young adult patients with acute attacks of acute intermittent porphyria tachycardia and hypertension were prominent features of the illness. Urinary catecholamine excretion was increased in both patients in whom it was measured. The effect of the beta-adrenergic blocking drug propranolol was assessed in each case. The dose varied from 40 to 240 mg daily. A response in the form of a reduction in heart rate and blood pressure was noted in each case, and in one case a marked alleviation of abdominal pain followed administration of the drug.

Propranolol, when given in high dosage to rats, did not induce an increase in hepatic delta-aminolaevulic acid synthetase, an enzyme which is raised in human and drug-induced animal porphyria. The use of propranolol is therefore unlikely to aggravate or precipitate an attack of acute intermittent porphyria.

Full text

PDF
260

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dowdle E. B., Mustard P., Eales L. Delta-aminolaevulinic acid synthetase activity in normal and porphyric human livers. S Afr Med J. 1967 Nov 4;41(42):1093–1096. [PubMed] [Google Scholar]
  2. GIBSON J. B., GOLDBERG A. The neuropathology of acute porphyria. J Pathol Bacteriol. 1956 Apr;71(2):495–509. doi: 10.1002/path.1700710222. [DOI] [PubMed] [Google Scholar]
  3. GOLDBERG A. Acute intermittent porphyria: a study of 50 cases. Q J Med. 1959 Apr;28(110):183–209. [PubMed] [Google Scholar]
  4. Granick S. The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. J Biol Chem. 1966 Mar 25;241(6):1359–1375. [PubMed] [Google Scholar]
  5. MAUZERALL D., GRANICK S. The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. J Biol Chem. 1956 Mar;219(1):435–446. [PubMed] [Google Scholar]
  6. Marver H. S., Tschudy D. P., Perlroth M. G., Collins A. Delta-aminolevulinic acid synthetase. I. Studies in liver homogenates. J Biol Chem. 1966 Jun 25;241(12):2803–2809. [PubMed] [Google Scholar]
  7. Moore M. R., Battistini V., Beattie A. D., Goldberg A. The effects of certain barbiturates on the hepatic porphyrin metabolism of rats. Biochem Pharmacol. 1970 Mar;19(3):751–757. doi: 10.1016/0006-2952(70)90238-8. [DOI] [PubMed] [Google Scholar]
  8. Moore M. R., Beattie A. D., Thompson G. G., Goldberg A. Depression of delta-aminolaevulic acid dehydrase activity by ethanol in man and rat. Clin Sci. 1971 Jan;40(1):81–88. doi: 10.1042/cs0400081. [DOI] [PubMed] [Google Scholar]
  9. PISANO J. J. A simple analysis for normetanephrine and metanephrine in urine. Clin Chim Acta. 1960 May;5:406–414. doi: 10.1016/0009-8981(60)90146-7. [DOI] [PubMed] [Google Scholar]
  10. Schley G., Bock K. D., Hocevar V., Merguet P., Rausch-Stroomann J. G., Schröder E., Schümann H. J. Hochdruck und Tachykardie bei der akuten intermittierenden Porphyrie. Klin Wochenschr. 1970 Jan 1;48(1):36–42. doi: 10.1007/BF01486127. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES